Douglas W. Blayney, MD, professor of internal medicine, University of Michigan School of Medicine, and medical director of the school’s Comprehensive Cancer Center, is the new ASCO president-elect. In addition, four news members were elected to the ASCO Board of Directors beginning in June 2008: Bruce E. Johnson, MD, and Sandra Swain, MD (undesignated specialty); Monica M. Bertagnolli, MD (surgical oncologist); and Robert Langdon, Jr., MD (community oncologist).
Mary-Claire King, PhD, who serves as the American Cancer Society Research Professor of Medicine and Genome Sciences, University of Washington, Seattle, will receive ASCO’s Science of Oncology Award for her work on the genomic localization of the BRCA1 gene.
Patricia A. Ganz, MD, professor of health services and medicine, UCLA, and director of the Division of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center, will receive the American Cancer Society Award at the ASCO annual meeting. She will present a lecture on improving outcomes for cancer survivors.
Nancy E. Davidson, MD, professor of oncology and breast cancer research chair in oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, was honored with the 11th Annual AACR-Women in Cancer Research-Charlotte Friend Memorial Lectureship at the recent AACR annual meeting, for her accomplishments in translational cancer science, including pivotal discoveries regarding the epigenetic regulation of estrogen receptors.
John Mendelsohn, MD, president of The University of Texas M.D. Anderson Cancer Center, was awarded AACR’s Dorothy P. Landon Prize for his pioneering translational research on targeting signal transduction mediated by tyrosine kinases that led to the development of C225 (cetuximab).
The Stanford University School of Medicine has received a $43.58 million grant from the California Institute for Regenerative Medicine, toward funding a new building that will house stem cell research on campus, to be called Stanford Institutes of Medicine 1 (SIM1). Irving Weissman, MD, director of Stanford University’s Stem Cell Biology and Regenerative Medicine Institute, said that “SIM1 will bring together a group of scientists interested in all aspects of stem cell biology and cancer stem cell research.”
Paulo Hoff, MD, hasbeen named director of medical oncology at the Faculdade de Medicina, Universidade de So Paulo, Brazil. He will continue as executive director of the cancer center at the Sirio Libanes Hospital.
Harald zur Hausen, DSc, MD, internationally recognized for his research showing the role of human papillomavirus as the etiological agent of cervical cancer, received the AACR Award for Lifetime Achievement at the 2008 AACR annual meeting in honor of his life’s work devoted to the study of viruses and cancer.